Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Enwave Corporation took a tumble today and lost -€0.009 (-6.670%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -6.670% | -4.545% | -25.000% | -54.348% | -46.610% | -41.121% | -80.675% |
| Aurinia Pharmaceuticals Inc. | -0.640% | -5.914% | -13.194% | 71.211% | -2.561% | 17.819% | 9.238% |
| Spectral Medical Inc | 2.440% | -1.754% | 2.439% | 66.337% | 5.660% | 296.226% | 265.217% |
| Xenon Pharmaceuticals Inc. | - | 0.000% | 10.476% | 114.815% | 52.632% | 74.699% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license